Professional Documents
Culture Documents
A monthly summary of the epidemiological data on selected Vaccine‐preventable diseases in the European Region
Table 1: Reported measles cases for the period January — December 2017 (data as of 02 February 2018)
Incidence Rate Month and year of rash onset
Total Total
Jan - Dec 17 Month & year
Country Population in (per 1 million measles
2017
1
2 cases Jan-17 Feb-17 Mar-17 Apr-17 May-17 Jun-17 Jul-17 Aug-17 Sep-17 Oct-17 Nov-17 Dec-17 of last report
population)
For tables 1-4, the reporting of these data by year and month are based on cases with disease onset date during the above 12-month period and corresponding month. Where the disease onset date was unavailable, cases
with the date of notification reported during these respective time periods were included as date of onset. These reports produced by national or partner agencies may differ if other dates (e.g. date of case reporting) were
used.
No. 1/2018
WHO EpiData
Table 2: Reported rubella cases for the period January — December 2017 (data as of 02 February 2018)
No. 1/2018
WHO EpiData
Table 3: Measles classification, reporting and surveillance performance, January — December 2017 (data as of 02 February 2018)
2016
2017
(as of 02 February 2018)
Classification Reporting Surveillance Indicators
Discarded Measles
Im ported cases
Total
Measles Death
Origin of infection
investigation rate
Rate of discarded
Month & year of
Incidence Annualized
5
Country
Lab confirmed
Population in
5
Total
Tim eliness of
Total
5
Com pleteness
4
investigation
Laboratory
Total measles
last report
compatible
Timeliness
Rate measles Incidence Rate
Clinically
1
measles
Epi-Link
2017
6
3
(per 1 million cases (per 1 million
cases
3
death cases
5
2 2
population) population)
No. 1/2018
WHO EpiData
Table 4: Rubella classification, reporting and surveillance performance, January — December 2017 (data as of 02 February 2018)
2016
2017
(as of 02 February 2018)
Discarded Rubella
Imported cases
Origin of infection
investigation rate
Rate of discarded
Total Population Total
5
Country Incidence
Lab confirmed
5
Timeliness of
5
Completeness
4
1
rubella
investigation
Laboratory
in 2017 Total rubella
last report
compatible
Incidence Rate
Timeliness
Rate
Clinically
Epi-Link
6
3 3
(per 1 million cases (per 1 million cases
cases
5
5
population)2 population) 2
No. 1/2018
WHO EpiData
Table 5: Measles and rubella laboratory test results, January — December 2017 (data as of 02 February 2018)
Measles Rubella Reporting to CISID / MRLDMS
% sequencing % sequencing
Country Total Genotypes Total Genotypes %
Positive for reported Positive for reported % Timeli- Month of
specimens 1
reported to specimens 1
reported to Complete-
1 measles (%) 2 within 60 1 rubella (%) 3 within 60 ness last report
tested MeaNS 2 tested RubeNS 3 ness
days days
*Specimen based data are not population based, and should not be interpreted as indicators for epidemiological surveillance. Laboratories may have received more than 1 clinical sample or may have
conducted more than 1 test for a given case reported in Table 1.
No. 1/2018
WHO EpiData
Figure 1: Top 10 countries with Measles Cases in European Region, 2017* (data as of 02 February 2018)
Romania (n=5562)
Italy (n=5006)
Ukraine (n=4767)
Greece (n=967)
Germany (n=927)
Serbia (n=702)
Tajikistan (n=649)
France (n=520)
Russian Federation (n=408)
Belgium (n=369)
Figure 2: Age and vaccination status of measles cases in Romania, 2016 — 2017* (data as of 02 February 2018)
90% 90%
80% 80%
70% 70%
60% 60%
50% 50%
40% 40%
30% 30%
20% 20%
10% 10%
0% 0%
<1 1–4 5–9 10–14 15–19 20–29 30+ <1 1–4 5–9 10–14 15–19 20–29 30+
(n=408) (n=1020) (n=456) (n=192) (n=118) (n=134) (n=102) (n=1088) (n=1970) (n=1044) (n=450) (n=280) (n=356) (n=374)
Age group Age group
0 doses 1 dose 2+ doses Unknown 0 doses 1 dose 2+ doses Unknown
Figure 3: Age and vaccination status of measles cases in Italy, 2016 — 2017* (data as of 02 February 2018)
90% 90%
80% 80%
70% 70%
60% 60%
50% 50%
40% 40%
30% 30%
20% 20%
10% 10%
0% 0%
<1 1–4 5–9 10–14 15–19 20–29 30+ <1 1–4 5–9 10–14 15–19 20–29 30+
(n=64) (n=169) (n=74) (n=67) (n=56) (n=173) (n=259) (n=284) (n=591) (n=236) (n=187) (n=278) (n=1339) (n=2091)
Age group Age group
0 doses 1 dose 2+ doses Unknown 0 doses 1 dose 2+ doses Unknown
Contact us: Vaccine‐preventable Diseases and Immuniza on Programme , WHO Regional Office for Europe
Tel.: +45 45 33 70 00 E‐mail: eumeasles@who.int and/or eucddata@who.int
Web site: h p://www.euro.who.int/vaccine © World Health Organiza on, 2017.
No. 1/2018